Cigna Stock Ready to Bounce Off Bullish Trendline
Though Cigna Group (NYSE:CI) stock was last seen down 1% to trade at $343.11, it's not too far removed from its March 28, record high of $365.71, and sports a 34.6% year-over-year lead.
4 HMO Stocks to Watch Amid Persistent Industry Challenges
The Medical-HMO industry continues to witness an expanding customer base resulting from contract wins. However, high technology expenses and a shortage of medical personnel are a concern.
Compared to Estimates, Cigna (CI) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for Cigna (CI) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street e...
Cigna (CI) Q1 Earnings Beat on Client Wins in Evernorth Unit
Cigna's (CI) Q1 results reflect strong organic growth in the Evernorth Health Services unit. It expects adjusted EPS of at least $28.40 for 2024, up from the earlier guidance of at least $28.25.
The Cigna Group (CI) Q1 2024 Earnings Call Transcript
The Cigna Group (NYSE:CI ) Q1 2024 Earnings Call Transcript May 2, 2024 8:30 AM ET Company Participants Ralph Giacobbe - SVP of IR David Cordani - Chairman and CEO Brian Evanko - CFO, and President...
Cigna (CI) Q1 Earnings and Revenues Beat Estimates
Cigna (CI) came out with quarterly earnings of $6.47 per share, beating the Zacks Consensus Estimate of $6.17 per share. This compares to earnings of $5.41 per share a year ago.
Cigna's stock jumps 2.7% after earnings beat estimates and company raises guidance
Cigna Group's stock CI, +0.04% rose 2.7% early Thursday, after the healthcare and insurance company posted better-than-expected first-quarter earnings and raised its guidance. The company had a net...
Cigna sees strong annual profit on lower costs, pharmacy benefit strength
Health insurer Cigna Group raised its annual profit forecast on Thursday, as lower-than-expected medical costs and strength in its pharmacy benefit management unit helped it beat first-quarter earn...
Why Earnings Season Could Be Great for Cigna Group (CI)
Cigna Group (CI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Analyzing How You Should Play Cigna (CI) Ahead of Q1 Earnings
The first-quarter results of Cigna (CI) are likely to reflect expanding commercial middle market memberships and growth in Cigna Healthcare profits.
Unveiling Cigna (CI) Q1 Outlook: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Cigna (CI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qua...
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
Cigna plans to make close copies of AbbVie's blockbuster arthritis drug Humira available with no out-of-pocket payment to eligible patients in the U.S. using its specialty pharmacy beginning in Jun...
Cigna (CI) Stock Dips While Market Gains: Key Facts
In the closing of the recent trading day, Cigna (CI) stood at $352.65, denoting a -0.15% change from the preceding trading day.
Here's Why Cigna (CI) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why the Market Dipped But Cigna (CI) Gained Today
Cigna (CI) closed at $348.78 in the latest trading session, marking a +0.78% move from the prior day.
Related Companies